Just in time: An update on continuum neurogenetics

CONTINUUM Lifelong Learning in Neurology

Volumn 17, Issue 2, 2011, Pages 239-248

  Rost, Natalia S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; MITOCHONDRIAL DNA;

AUTISM; CADASIL; CEREBROVASCULAR DISEASE; ESSENTIAL TREMOR; GAUCHER DISEASE; GENETIC ANALYSIS; HUMAN; MEDICAL GENETICS; MITOCHONDRIAL DNA DISORDER; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PARKINSON DISEASE; REVIEW; SHY DRAGER SYNDROME; STROKE;

EID: 79955841681     PISSN: 10802371     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.CON.0000396959.52198.1b     Document Type: Review

References (43)

1. Gusella JF, MacDonald ME. Huntington's disease: the case for genetic modifiers. Genome Med 2009;1(8):80.
2. Opherk C, Peters N, Holtmannspötter M, et al. Heritability of MRI lesion volume in CADASIL: evidence for genetic modifiers. Stroke 2006;37(11):2684-2689. (Pubitemid 44922526)
3. Bultron G, Kacena K, Pearson D, et al. The risk of Parkinson's disease in type 1 Gaucher disease. J Inherit Metab Dis 2010;33(2):167-173.
4. Evatt ML, Delong MR, Khazai N, et al. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 2008; 65(10):1348-1352.
5. Sanchez B, Relova JL, Gallego R, et al. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum. J Neurosci Res 2009;87(3):723-732.
6. Knekt P, Kilkkinen A, Rissanen H, et al. Serum vitamin D and the risk of Parkinson disease. Arch Neurol 2010;67(7):808-811.
7. Butler MW, Burt A, Edwards T, et al. Vitamin D receptor gene confers genetic risks for Parkinson disease. Ann Hum Genet 2011;75(2):201-210.
8. Marder KS, Tang MX, Mejia-Santana H, et al. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Arch Neurol 2010;67(6):731-738.
9. Bademci G, Edwards TL, Torres AL, et al. A rare novel deletion of tyrosine hydroxylase gene in Parkinson disease. Hum Mutat 2010;31(10):E1767- E1771.
10. Hamza TH, Zabetian CP, Tenesa A, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 2010;42(9): 781-785.
11. Scholz SW, Houlden H, Schulte C, et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 2009;65(5):610-614.
12. Al-Chalabi A, Dürr A, Wood NW, et al. NNIPPS Genetic Study Group. Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS One 2009;4(9):e7114.
13. Sullivan KL, Hauser RA, Zesiewicz TA. Essential tremor. Epidemiology, diagnosis, and treatment. Neurologist 2004;10(5): 250-258. (Pubitemid 39223711)
14. Stefansson H, Steinberg S, Petursson H, et al. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet 2009;41(3):277-279.
15. Mi S, Hu B, Hahm K, et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 2007;13(10): 1228-1233. (Pubitemid 47530642)
16. BiałeckaM,KurzawskiM,Tan EK, Drozdzik M. Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson's disease in a Polish population, and a meta-analysis. Neurosci Lett 2010;472(1):53-55.
17. Hafler DA. Multiple sclerosis. J Clin Invest 2004;113(6):788-794. (Pubitemid 38544133)
18. Hauser SL, Fleischnick E, Weiner HL, et al. Extended major histocompatibility complex haplotypes in patients with multiple sclerosis. Neurology 1989;39(2 pt 1):275-277. (Pubitemid 19059321)
19. Sawcer S, Ban M, Maranian M, et al. A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 2005;77(3): 454-467. (Pubitemid 41192651)
20. International Multiple Sclerosis Genetics Consortium; Hafler DA, Compston A, Sawcer S, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007;357(9):851-862. (Pubitemid 47347319)
21. De Jager PL, Jia X, Wang J, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009;41(7):776-782.
22. Baranzini SE, Wang J, Gibson RA, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009; 18(4):767-778.
23. Maier LM, Lowe CE, Cooper J, et al. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet 2009;5(1):e1000322.
24. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86(5):749-764.
25. Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008;358(7):667-675. (Pubitemid 351240746)
26. Wang K, Zhang H, Ma D, et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009;459(7246):528-533.
27. Glessner JT, Wang K, Cai G, et al. Autism genome-wide copy number variation reveals iquitin and neuronal genes. Nature 2009;459(7246):569-573.
28. Meschia JF. Stroke genome-wide association studies: the large numbers imperative. Stroke 2010;41(4):579-580.
29. Ikram MA, Seshadri S, Bis JC, et al. Genomewide association studies of stroke. N Engl J Med 2009;360(17):1718-1728
30. International Stroke Genetics Consortium and Wellcome Trust Case-Control Consortium 2. Failure to validate association between 12p13 variants and ischemic stroke. N Engl J Med 2010;362(16):1547-1550.
31. Lanktree MB, Dichgans M, Hegele RA. Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke 2010;41(4):825-832.
32. Gschwendtner A, Bevan S, Cole JW, et al. Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol 2009;65(5):531-539.
33. Gudbjartsson DF, Arnar DO, Helgadottir A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007;448(7151):353-357. (Pubitemid 47080348)
34. Anderson CD, Biffi A, Rost NS, et al. Chromosome 9p21 in ischemic stroke: population structure and meta-analysis. Stroke 2010;41(6):1123-1131.
35. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol 2007;6(2):149-161. (Pubitemid 46097541)
36. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a mendelian condition causing stroke and vascular dementia. Ann N Y Acad Sci 1997;826:213-217. (Pubitemid 27478042)
37. Dichgans M, Mayer M, Uttner I, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998; 44(5):731-739. (Pubitemid 28516043)
38. Opherk C, Peters N, Herzog J, et al. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain 2004;127(pt 11):2533-2539. (Pubitemid 39472981)
39. Debette S, Bis JC, Fornage M, et al. Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium. Stroke 2010;41(2):210-217.
40. Biffi A, Anderson CD, Nalls MA, et al. Principal-component analysis for assessment of population stratification in mitochondrial medical genetics. Am J Hum Genet 2010;86(6):904-917.
41. Saxena R, de Bakker PI, Singer K, et al. Comprehensive association testing of common mitochondrial DNA variation in metabolic disease. Am J Hum Genet 2006;79(1):54-61. (Pubitemid 43927376)
42. Chinnery PF, Elliott HR, Syed A, Rothwell PM. Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study. Lancet Neurol 2010;9(5):498-503.
43. Anderson CD, Biffi A, Rahman R, et al; International Stroke Genetics Consortium. Common mitochondrial sequence variants in ischemic stroke [published online ahead of print September 13, 2010]. Ann Neurol doi:10.1002/ana.22108.